bioRxivNeurosciencePreprint
α-synuclein over expression, NRF2 suppression, and enhanced ferroptosis creates a vicious cycle of neuronal loss in Parkinson's disease
Annadurai AnandhaniD, W Chen, Lan Ngoc-NguyeniD, Lalitha MadhavaniD, Matthew B. DodsoniD, D.D. Zhang
Abstract
Parkinsons disease (PD) is the second most common neurodegenerative disorder, affecting millions each year. Most PD cases ([~]90%) are sporadic, resulting from the age-dependent accumulation of pathogenic effects. One key pathological hallmark of PD progression is the accumulation of alpha-synuclein (-syn), which has been shown to negatively affect neuronal function and viability. Here, using 3- and 6-month-old Nrf2+/+ and Nrf2-/- mice overexpressing human -syn (PD model), we show that loss of NRF2 increases markers of ferroptosis across PD-relevant brain regions. Increased ferroptosis was associated with an age- and genotype-dependent increase in -syn pathology and behavioral deficits. Finally, we demonstrate that -syn overexpression sensitizes neuronal cells and ex vivo brain slices to ferroptosis induction, which may be due to -syn suppression of NRF2 at the protein level. Altogether, these results indicate that NRF2 is a critical anti-ferroptotic mediator of neuronal survival, and that the vicious cycle of -syn overexpression and NRF2 suppression, leading to enhanced neuronal ferroptotic cell death, could represent a targetable and currently untapped means of preventing PD onset and progression.
Abstract summary
Claude Opus 5.5 · xhigh effort · 2 Nov 2026 · from the abstract
In Parkinson's disease models, alpha-synuclein overexpression sensitizes neurons to ferroptosis, potentially by suppressing NRF2 protein, while Nrf2 loss increases ferroptosis markers, alpha-synuclein pathology, and behavioral deficits.
Roughly 90% of Parkinson's disease (PD) cases are sporadic and characterized by age-dependent pathogenic accumulation of alpha-synuclein that impairs neuronal viability. By studying mice overexpressing human alpha-synuclein alongside neuronal cells and ex vivo brain slices, this work identifies a self-reinforcing loop linking alpha-synuclein accumulation, NRF2 suppression, and ferroptotic neuronal death.
Key results
ShownGenetic loss of Nrf2 elevates ferroptosis markers across PD-relevant brain regions and worsens alpha-synuclein pathology and behavioral deficits in an age- and genotype-dependent manner.
Shown in 3- and 6-month-old Nrf2+/+ and Nrf2-/- mice overexpressing human alpha-synuclein (no specific animal counts or effect sizes are reported in the abstract). · Abstract
ShownOverexpression of alpha-synuclein increases susceptibility to ferroptosis induction in neuronal cells and ex vivo brain slices, potentially via protein-level NRF2 suppression.
Demonstrated in neuronal cells and ex vivo brain slices overexpressing alpha-synuclein (no numerical measurements are provided in the abstract). · Abstract
Methods, data and reproducibility
The authors evaluated ferroptosis markers, alpha-synuclein pathology, and behavioral deficits across PD-relevant brain regions in 3- and 6-month-old Nrf2+/+ and Nrf2-/- mice overexpressing human alpha-synuclein. They also tested susceptibility to ferroptosis induction and NRF2 protein suppression upon alpha-synuclein overexpression in neuronal cells and ex vivo brain slices.
- 3- and 6-month-old Nrf2+/+ and Nrf2-/- mice overexpressing human alpha-synuclein · mouse (expressing human alpha-synuclein)
- Neuronal cells and ex vivo brain slices overexpressing alpha-synuclein
- Reproducibility gaps
- Sample sizes, specific ferroptosis markers, behavioral assay names, and data repositories are not stated in the abstract.
Limitations (2)
- All reported findings rely on Nrf2+/+ and Nrf2-/- mice, ex vivo brain slices, and neuronal cells overexpressing alpha-synuclein, without direct validation in human Parkinson's disease patient tissue. · noted in this summary
- Whether targeting the alpha-synuclein–NRF2–ferroptosis loop prevents Parkinson's disease onset or progression is proposed as a therapeutic concept rather than tested with an intervention in the abstract. · noted in this summary
Read this if you study neurodegeneration or Parkinson's disease mechanisms and want evidence linking alpha-synuclein toxicity to NRF2 suppression and ferroptotic cell death.
- Citations
- 48
- FWCI
- 5.66
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
Alberto Delaidelli, Mette Richner, … Asad Jan·Acta Neuropathologica CommunicationsPeer-reviewed·Jun 6, 2021
- Alpha-synuclein and neuromelanin converge to promote Parkinsons disease pathology
Alba Nicolau, Marta González-Sepúlveda, … Miquel Vila·bioRxiv·Oct 24, 2026
- LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri, Michel Brahic, … Aaron D. Gitler·Acta NeuropathologicaPeer-reviewed·Mar 29, 2019
- Nicotine Ameliorates α-synuclein Pre-formed Fibril-Induced Behavioral Deficits and Pathological Features in Mice
Zhangqiong Huang, Yue Pan, … Ying Guan·Applied Biochemistry and BiotechnologyPeer-reviewed·Jan 16, 2025
- The SNCA A53T mutation sensitizes human neurons and microglia to ferroptosis
Laura Mahoney‐Sanchez, Hannah J Lucas-Clarke, … Sonia Gandhi·bioRxiv·Oct 13, 2025
- Long-term exposure to PFE-360 in the AAV-α-synuclein rat model: findings and implications
Michael Aagaard Andersen, Florence Sotty, … Kenneth Vielsted Christensen·eNeuroPeer-reviewed·Nov 1, 2019